Answers are grounded in this paper and cite their sources.
Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue. However, their similar clinical manifestations, overlapping syndromes, evolution from one entity into another, as well as common autoantibody responses, suggest that autoimmune and autoinflammatory disorders may constitute distinct pathophysiologic processes on the basis of a different genetic background. Prognosis and effective therapeutic regimens are mostly based on the clinico-pathologic severity of the involved tissues or organs and not on the disease label.
No takes yet. Share an insight, caveat, or question.
Haralampos Μ. Moutsopoulos (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: